Frontiers in Oncology · 2022 · 17 citations · 29 references
MedicineBioinformaticsOncologyCellular MetabolismGynecologic OncologyMolecular OncologyCancer BiomarkersCancer GenomicsCancer MetabolismMetabolic ReprogrammingMolecular Tumor ProfilingOvarian CancerMetabolic Signature DiscoveryOvarian Cancer BiomarkersOvarian Cancer Prognostic BiomarkersOvarian Tumor BiomarkersPrognostic Gene Expression ProfilingPrognostic Signature DevelopmentSerous Ovarian TumorsTumor Metabolism
Background: The key biochemical feature of malignant tumor is the conversion of energy metabolism from oxidative phosphorylation to glycolysis, which provides sufficient capacity and raw materials for tumor cell rapid growth. Our study aims to construct a prognostic signature for ovarian cancer based on lactate metabolism-related genes (LMRGs). Methods: Data of ovarian cancer and non-diseased ovarian data were downloaded from TCGA and the GTEx database, respectively. LMRGs were obtained from GeneCards and MSigDB databases, and the differentially expressed LMRGs were identified using limma and DESeq2 R packages. Cox regression analysis and LASSO were performed to determine the LMRGs associated with OS and develop the prognostic signature. Then, clinical significance of the prognostic signature in ovarian cancer was assessed. Results: A total of 485 differentially expressed LMRGs in ovarian tissue were selected for subsequent analysis, of which 324 were up-regulated and 161 were down regulated. We found that 22 LMRGs were most significantly associated with OS by using the univariate regression analysis. The prognostic scoring model was consisted of 12 LMRGs (SLCO1B3, ERBB4, SLC28A1, PDSS1, BDH1, AIFM1, TSFM, PPARGC1A, HGF, FGFR1, ABCC8, TH). Kaplan-Meier survival analysis indicated that poorer overall survival (OS) in the high-risk group patients (P<0.0001). This prognostic signature could be an independent prognostic indicator after adjusting to other clinical factors. The calibration curves of nomogram for the signature at 1, 2, and 3 years and the ROC curve demonstrated good agreement between the predicted and observed survival rates of ovarian cancer patients. Furthermore, the high-risk group patients have much lower expression level of immune checkpoint-TDO2 compared with the low-risk group (P=0.024). Conclusions: We established a prognostic signature based on LMRGs for ovarian cancer, and highlighted emerging evidence indicating that this prognostic signature is a promising approach for predicting ovarian cancer prognosis and guiding clinical therapy.
29
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law, Yunshun Chen, Wei Shi et al. · Genome biology · 2014 · 6.7K citations · Full text
Glucose feeds the TCA cycle via circulating lactate
Sheng Hui, Jonathan M. Ghergurovich, Raphael J. Morscher et al. · Nature · 2017 · 1.7K citations
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten, Sheryl K. Elkin, Elisa Arthur et al. · Clinical Cancer Research · 2015 · 814 citations · Full text
Lactate dehydrogenase activity drives hair follicle stem cell activation
Aimee Flores, John C. Schell, Abigail S. Krall et al. · Nature Cell Biology · 2017 · 294 citations · Full text